Literature DB >> 16775029

Human vascular smooth muscle cells express a urate transporter.

Karen L Price1, Yuri Y Sautin, David A Long, Li Zhang, Hiroki Miyazaki, Wei Mu, Hitoshi Endou, Richard J Johnson.   

Abstract

An elevated serum uric acid is associated with the development of hypertension and renal disease. Renal regulation of urate excretion is largely controlled by URAT1 (SLC22A12), a member of the organic anion transporter superfamily. This study reports the specific expression of URAT1 on human aortic vascular smooth muscle cells, as assessed by reverse transcription-PCR and Western blot analysis. Expression of URAT1 was localized to the cell membrane. Evidence that the URAT1 transporter was functional was provided by the finding that uptake of 14C-urate was significantly inhibited in the presence of probenecid, an organic anion transporter inhibitor. It is proposed that URAT1 may provide a mechanism by which uric acid enters the human vascular smooth muscle cell, a finding that may be relevant to the role of uric acid in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775029     DOI: 10.1681/ASN.2006030264

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

3.  Uric acid inhibits placental system A amino acid uptake.

Authors:  S A Bainbridge; F von Versen-Höynck; J M Roberts
Journal:  Placenta       Date:  2008-12-05       Impact factor: 3.481

Review 4.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

5.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

6.  Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake.

Authors:  Carlos A Roncal-Jimenez; Miguel A Lanaspa; Christopher J Rivard; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Diana Jalal; Ana Andres-Hernando; Katsuyuki Tanabe; Magdalena Madero; Nanxing Li; Christina Cicerchi; Kim Mc Fann; Yuri Y Sautin; Richard J Johnson
Journal:  Metabolism       Date:  2011-04-12       Impact factor: 8.694

7.  Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Shigeko Hara; Carlos A Roncal-Jimenez; Petter Bjornstad; Takahiko Nakagawa; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Bernardo Rodriguez-Iturbe; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-12-04       Impact factor: 10.190

8.  Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Theodora Szasz; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

9.  [Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

Authors:  S Unger; A-K Tausche; S Kopprasch; S R Bornstein; M Aringer; J Grässler
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

Review 10.  Uric acid: an old actor for a new role.

Authors:  E Manzato
Journal:  Intern Emerg Med       Date:  2007-03       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.